Victoria’s first mRNA innovation hub backed by state government
A collaborative team of Melbourne researchers from Monash University and the University of Melbourne have received $5.4 million from the Victorian government to establish The Victorian mRNA Innovation Hub to develop next-generation mRNA vaccines and
Burnet teams up with Monash and BioCurate to develop novel HIV antivirals
Burnet Institute, in collaboration with MIPS has received Proof of Concept funding from BioCurate to develop next-generation HIV antivirals.
The “master regulator” of inflammation: Monash researchers publish review on promising emerging drug target to treat chronic inflammatory states
Monash researchers, in collaboration with Queen Mary University of London, have published a state-of-the-art review on an emerging druggable target called FPR2, a key receptor involved in the regulation of inflammation.
New development for hormone-free male contraceptive pill
A new study led by a team of Monash researchers working to develop a male contraceptive pill has identified that stinging nettle leaf extract has the potential to block a protein that controls the movement of sperm.
WEHI and Monash drug discovery team nominated as finalists in prestigious Eureka Prizes
In recognition of their pioneering research, a team of Melbourne scientists from WEHI and Monash University have been shortlisted as finalists in this year’s Australian Museum Eureka Prizes.
Biotech start-up receives funding for anti-inflammatory research
A new start-up company led by researchers at The Australian National University and Monash University has received funding to develop a method to block inflammation caused by a number of common diseases, including cardiovascular disease,
New Monash biotech company receives funding to tackle cognitive disorders
A new Monash biotech company called Phrenix Therapeutics has received funding to advance research to develop new therapeutics for cognitive disorders, particularly in schizophrenia.
New research into diabetes management in people who are frail
Monash University’s Centre for Medicine Use and Safety (CMUS) in collaboration with the Baker Heart and Diabetes Institute has released new research into the management of diabetes in people who are frail.
Nanoneedles and navigating the path to commercialisation: A guide for academics
Nanotechnology researchers from Monash University have published an article in the high impact journal, Nature Nanotechnology, highlighting the opportunities and challenges involved in commercialising nanoneedle technology for sensing and clinical